Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis

ABSTRACT Introduction: Amyotrophic lateral sclerosis (ALS) is a debilitating neurologic disorder with poor survival rates and no clear biomarkers for disease diagnosis and prognosis. Methods: We compared serum microRNA (miRNA) expression from patients with ALS with healthy controls and patients with...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Muscle & nerve Ročník 58; číslo 2; s. 261 - 269
Hlavní autoři:	Raheja, Radhika, Regev, Keren, Healy, Brian C., Mazzola, Maria Antonietta, Beynon, Vanessa, Von Glehn, Felipe, Paul, Anu, Diaz‐Cruz, Camilo, Gholipour, Taha, Glanz, Bonnie I., Kivisakk, Pia, Chitnis, Tanuja, Weiner, Howard L., Berry, James D., Gandhi, Roopali
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Wiley Subscription Services, Inc 01.08.2018
Témata:	Adult ALS Alzheimer Disease - blood Alzheimer Disease - physiopathology Alzheimer's disease Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - blood Amyotrophic Lateral Sclerosis - physiopathology Biomarkers Biomarkers - blood Cohort Studies Cross-Sectional Studies Diagnosis disease comparisons Disease control Disease Progression Female Gene Expression Regulation Humans longitudinal analysis Longitudinal Studies Male Medical prognosis microRNA MicroRNAs - blood Middle Aged miRNA Multiple sclerosis Multiple Sclerosis - blood Multiple Sclerosis - physiopathology Muscles Neurodegenerative diseases Parameter identification Patients Ribonucleic acid RNA serum ALS longitudinal analysis microRNA disease comparisons serum biomarkers
ISSN:	0148-639X, 1097-4598, 1097-4598
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!